(Q39280599)

10 September 2017

1 reference

title

Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons (English)

1 reference

10 September 2017

0 references

0 references

Michael Alifrangis

3

0 references

author name string

Reginald A Kavishe

series ordinal

1

1 reference

PubMed ID

28467668

10 September 2017

Jan B Koenderink

series ordinal

2

1 reference

PubMed ID

28467668

10 September 2017

language of work or name

English

0 references

publication date

3 May 2017

1 reference

10 September 2017

1 reference

10 September 2017

284

1 reference

10 September 2017

16

1 reference

10 September 2017

2579-2591

1 reference

Oxidative stress in malaria; implications for prevention and therapy

10 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Fate of haem iron in the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Hemin lyses malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Characterization of heme as activator of Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Oxidative stress in patients with non-complicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Heme oxygenase-1 affords protection against noncerebral forms of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Oxidative stress in malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Impact of placental Plasmodium falciparum malaria on the profile of some oxidative stress biomarkers in women living in Yaoundé, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Peroxiredoxins in malaria parasites: parasitologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Superoxide radical and superoxide dismutases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Trends in oxidative aging theories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Redox and antioxidant systems of the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Thioredoxin and related molecules--from biology to health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Cloning and expression of a novel mammalian thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Identification of natural killer enhancing factor as a major antioxidant in human red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Thioredoxin networks in the malarial parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Thioredoxin peroxidases of the malarial parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Roles of 1-Cys peroxiredoxin in haem detoxification in the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Isolation and functional analysis of two thioredoxin peroxidases (peroxiredoxins) from Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Structural and biochemical characterization of a mitochondrial peroxiredoxin from Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Crystal structure of a novel Plasmodium falciparum 1-Cys peroxiredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Plasmoredoxin, a novel redox-active protein unique for malarial parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

The glutathione S-transferase from Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Structural, functional and unfolding characteristics of glutathione S-transferase of Plasmodium vivax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Plasmodium falciparum glutathione S-transferase--structural and mechanistic studies on ligand binding and enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Quinoline antimalarials: mechanisms of action and resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Glutathione-S-transferase activity in malarial parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Piperaquine: a resurgent antimalarial drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

A common mechanism for blockade of heme polymerization by antimalarial quinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Discovery, mechanisms of action and combination therapy of artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Yeast model uncovers dual roles of mitochondria in action of artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Neurotoxicity in animals due to arteether and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Localization of artesunate and its derivatives in the pregnant rat and fetus following oral administration and relationship to developmental toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14097

21 January 2018

Identifiers

DOI

10.1111/FEBS.14097

1 reference

10 September 2017

1 reference

PubMed ID

28467668